Concepedia

Andrew James Wiele

AJ

4

Publications

113

Citations

4

H-Index

2021

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Andrew James Wiele is an author at The University of Texas MD Anderson Cancer Center specializing in cancer research, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2021–2023

4

Publications

4

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

Andrew James Wiele, Tharakeswara Bathala, Andrew W. Hahn et al. · The Oncologist · 2021 · 35 citations · Full text

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Nathaniel R. Wilson, Andrew James Wiele, Devaki Shilpa Surasi et al. · Clinical Genitourinary Cancer · 2021 · 34 citations · Full text

, , +7

Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma

Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao et al. · Cancers · 2021 · 32 citations · Full text

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

Andrew W. Hahn, Ritesh R. Kotecha, Paul V. Viscuse et al. · European Urology Focus · 2023 · 12 citations · Full text

Rows per page

1–4 of 4